• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性骨髓增殖性疾病中的降钙素基因甲基化

Calcitonin gene methylation in chronic myeloproliferative disorders.

作者信息

Ihalainen J, Juvonen E, Savolainen E R, Ruutu T, Palotie A

机构信息

Department of Clinical Chemistry, University of Helsinki, Finland.

出版信息

Leukemia. 1994 Feb;8(2):230-5.

PMID:8309247
Abstract

Alterations in DNA methylation appear to be an integral part of the malignant transformation. For example, the p15 region of chromosome 11 with multiple genes related to cell growth regulation exhibits different methylation patterns in the 5' area of the calcitonin A gene in healthy bone marrow cells, and in leukemic cell populations. In this work the methylation status of the 5' area of the calcitonin gene in myeloproliferative disorders (MPD) other than chronic myeloid leukemia (CML) is studied. A total number of 37 patients with polycythemia vera, essential thrombocythemia, or myelofibrosis were studied. A control group of 18 healthy persons and patients with reactive hematologic changes was included. The DNA isolated from peripheral blood or bone marrow cells was digested with the methylation-sensitive HpaII restriction enzyme. A Southern blot was hybridized with a 1.7 kb probe specific to the 5' area of the calcitonin gene. The result was visualized autoradiographically and analyzed with a densitometer. The results have been expressed as ratios between the abnormal and normal autoradiography band intensities, referred to as the calc-value or CALC. An increase in the calc-value signifies increasing methylation. In the control group the calc-value had a mean of 0.274. The myelofibrosis patients exhibited very strong hypermethylation in the calcitonin gene 5' area, with a mean calc-value of 11.1 (median 2.6). The polycythemia vera patients showed considerable variation in their methylation status, with a mean value of 1.52. The essential thrombocythemia patients exhibited weak hypermethylation, with a mean calc-value of 0.58. A correlation between karyotypic abnormalities and hypermethylation was observed. Complicated forms of MPD exhibited higher levels of methylation than the uncomplicated disease forms.

摘要

DNA甲基化改变似乎是恶性转化的一个重要组成部分。例如,11号染色体的p15区域含有多个与细胞生长调控相关的基因,在健康骨髓细胞和白血病细胞群体中,降钙素A基因5'区域呈现出不同的甲基化模式。在这项研究中,我们研究了除慢性粒细胞白血病(CML)之外的骨髓增殖性疾病(MPD)中降钙素基因5'区域的甲基化状态。总共研究了37例真性红细胞增多症、原发性血小板增多症或骨髓纤维化患者。纳入了18名健康人和有反应性血液学改变的患者作为对照组。从外周血或骨髓细胞中分离出的DNA用甲基化敏感的HpaII限制性内切酶进行消化。用一个针对降钙素基因5'区域的1.7 kb探针进行Southern印迹杂交。结果通过放射自显影进行可视化,并使用密度计进行分析。结果以异常和正常放射自显影带强度之间的比率表示,称为calc值或CALC。calc值增加表示甲基化增加。在对照组中,calc值的平均值为0.274。骨髓纤维化患者在降钙素基因5'区域表现出非常强烈的高甲基化,平均calc值为11.1(中位数为2.6)。真性红细胞增多症患者的甲基化状态存在相当大的差异,平均值为1.52。原发性血小板增多症患者表现出微弱的高甲基化,平均calc值为0.58。观察到核型异常与高甲基化之间存在相关性。MPD的复杂形式比非复杂疾病形式表现出更高水平的甲基化。

相似文献

1
Calcitonin gene methylation in chronic myeloproliferative disorders.慢性骨髓增殖性疾病中的降钙素基因甲基化
Leukemia. 1994 Feb;8(2):230-5.
2
[Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].慢性骨髓增殖性疾病诊断的新方法——JAK2 突变检测
Orv Hetil. 2006 Nov 12;147(45):2175-9.
3
Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.慢性骨髓增殖性疾病的发病机制:真性红细胞增多症、原发性血小板增多症、特发性骨髓化生及慢性粒细胞白血病。
Semin Hematol. 1999 Jan;36(1 Suppl 2):3-8.
4
Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).慢性骨髓增殖性疾病(MPD)、原发性血小板增多症(ET)、真性红细胞增多症(PV)和慢性特发性骨髓纤维化(CIMF)的现行诊断标准。
Pathol Biol (Paris). 2007 Mar;55(2):92-104. doi: 10.1016/j.patbio.2006.06.002. Epub 2006 Aug 21.
5
Hypermethylation of the calcitonin gene in the myelodysplastic syndromes.骨髓增生异常综合征中降钙素基因的高甲基化
Leukemia. 1993 Feb;7(2):263-7.
6
Infrequent hypermethylation of WIF-1 promoter in BCR/ABL-negative myeloproliferative disorders.BCR/ABL阴性骨髓增殖性疾病中WIF-1启动子的罕见高甲基化
Tokai J Exp Clin Med. 2007 Dec 20;32(4):131-5.
7
[Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].[骨髓活检在慢性骨髓增殖性疾病中的预后价值]
Recenti Prog Med. 2003 Jul-Aug;94(7-8):314-20.
8
The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.真性红细胞增多症、原发性血小板增多症和原发性骨髓纤维化中JAK2 V617F等位基因负荷——对疾病表型的影响
Eur J Haematol. 2007 Dec;79(6):508-15. doi: 10.1111/j.1600-0609.2007.00960.x. Epub 2007 Oct 23.
9
[Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome].[原发性血小板增多症。V617F JAK2突变对病理生理学、诊断及预后的作用]
Bull Acad Natl Med. 2007 Mar;191(3):535-48.
10
The role of beta-catenin in chronic myeloproliferative disorders.β-连环蛋白在慢性骨髓增殖性疾病中的作用。
Hum Pathol. 2008 Oct;39(10):1454-8. doi: 10.1016/j.humpath.2008.02.007. Epub 2008 Jul 11.

引用本文的文献

1
Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology.血栓性骨髓增殖性肿瘤的分子遗传学:对精准肿瘤学的启示
Diagnostics (Basel). 2023 Jan 3;13(1):163. doi: 10.3390/diagnostics13010163.
2
Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies.骨髓增殖性肿瘤中的表观遗传学异常:新型治疗策略的靶点。
Clin Epigenetics. 2011 Aug;2(2):197-212. doi: 10.1007/s13148-011-0050-6. Epub 2011 Jul 9.
3
Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives.
骨髓增殖性肿瘤的表观遗传学治疗:证据与展望。
J Cell Mol Med. 2009 Aug;13(8A):1437-50. doi: 10.1111/j.1582-4934.2009.00827.x. Epub 2009 Jun 11.
4
A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis.一项针对原发性和原发性血小板增多症/真性红细胞增多症骨髓纤维化患者的5-氮杂胞苷II期研究。
Leukemia. 2008 May;22(5):965-70. doi: 10.1038/leu.2008.91. Epub 2008 Apr 3.